Aridhia, one of the world’s leading health and biomedical informatics companies, today announced that it has secured a substantial investment from Albion Ventures and Scottish Equity Partners (SEP), two of the UK’s largest venture capital groups.
The investment will give the company access to a deep pool of experience when the company is undergoing a rapid period of expansion across the globe.
Founded in 2008 by successful entrepreneur Dr David Sibbald OBE and Professor Andrew Morris, Dean and Professor of Medicine at the University of Dundee, Aridhia has built a sector-leading, differentiated informatics platform with cutting-edge analytical tools to support healthcare delivery and research, with a specific focus on chronic diseases. It has established an international client base and a network of major strategic partners, which includes Pivotal, a leading provider of application and data infrastructure software; and global life sciences company, Life Technologies, with which Aridhia is collaborating to support the Stratified Medicine Scotland Innovation Centre.
Dr David Sibbald, Co-founder and Chief Executive of Aridhia, added:
“We are excited to have gained the backing of Albion whose expertise in the healthcare IT sector convinced us that they would be ideal partners. Given our ambitious growth plans and the size of the opportunity, it was important to partner with a firm that had both the financial resources and a clear vision of how the market will evolve. We now look forward to working closely with Albion and SEP as we turn our vision of expansion into reality.”